Skip to main content

Advertisement

Log in

Case Series Study of Invasive Pulmonary Aspergillosis

  • Published:
Mycopathologia Aims and scope Submit manuscript

Abstract

Diagnosis of invasive pulmonary aspergillosis (IPA) is challenging. The objective of the study was to assess the value of microbiological tests to the diagnosis of IPA in the absence of non-specific radiological data. A retrospective study of 23 patients with suspicion of IPA and positivity of some microbiological diagnostic tests was performed. These tests included conventional microbiological culture, detection of Aspergillus galactomannan (GM) antigen and in some patients (1 → 3)-β-d-glucan (BDG) and Aspergillus fumigatus DNA using the LightCycler® SeptiFast test. In 10 patients with hematological malignancy, 6 cases were considered ‘probable’ and 4 ‘non-classifiable.’ In 8 patients with chronic lung disease, 7 cases were classified as ‘probable’ and 1 as ‘proven,’ and in 5 patients with prolonged ICU stay (>7 days), there were 2 ‘proven’ cases, 2 ‘non-classifiable’ and 1 putative case. Microbiological culture was positive in 17 cases and 18 Aspergillus spp. were isolated (one mixed culture). A. fumigatus was the most frequent (44.4%) followed by A. tubingensis. The Aspergillus galactomannan (GM) antigen assay was positive in 21 cases (91.3%). The GM antigen and the (1 → 3)-β-d-glucan (BDG) assays were both performed in 12 cases (52.2%), being positive in 9. The SeptiFast test was performed in 7 patients, being positive in 4. In patients with non-classifiable pulmonary aspergillosis and one or more positive microbiological tests, radiological criteria may not be considered a limiting factor for the diagnosis of IPA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Pagano L, Caira M, Candoni A, Offidani M, Martino B, Specchia G, et al. Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study. Haematologica. 2010;95:644–50.

    Article  PubMed  Google Scholar 

  2. Nucci M, Nouér SA, Cappone D, Anaissie E. Early diagnosis of invasive pulmonary aspergillosis in hematologic patients: an opportunity to improve the outcome. Haematologica. 2013;98:1657–60.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Holding KJ, Dworkin MS, Wan PC, Hanson DL, Klevens RM, Jones JL, et al. Aspergillosis among people infected with human immunodeficiency virus: incidence and survival. Adult and adolescent spectrum of HIV disease project. Clin Infect Dis. 2000;31:1253–7.

    Article  CAS  PubMed  Google Scholar 

  4. Bulpa P, Dive A, Sibille Y. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Resp J. 2007;30:782–800.

    Article  CAS  Google Scholar 

  5. Samarakoon P, Soubani AO. Invasive pulmonary aspergillosis in patients with COPD: a report of five cases and systematic review of the literature. Chron Resp Dis. 2008;5:19–27.

    Article  CAS  Google Scholar 

  6. Barberan J, Sanz F, Hernández JL, Merlos S, Malmierca E, Garcia-Perez FJ, et al. Clinical features of invasive pulmonary aspergillosis vs. colonization in COPD patients distributed by gold stage. J Infect. 2012;65:447–52.

    Article  PubMed  Google Scholar 

  7. Wessolossky M, Welch VL, Sen A, Babu TM, Luke DR. Invasive Aspergillus infections in hospitalized patients with chronic lung disease. Infect Drug Resist. 2013;6:33–9.

    PubMed  PubMed Central  Google Scholar 

  8. Garnacho-Montero J, Amaya-Villar R, Ortiz-Leyba C, León C, Álvarez-Lerma F, Nolla-Salas J, et al. Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome. Crit Care. 2005;9:R91–9. doi:10.1186/cc3488.

    Article  Google Scholar 

  9. Vandewoude KH, Blot SI, Depuydt P, Benoit D, Temmerman W, Colardyn F, et al. Clinical relevance of Aspergillus isolation from respiratory tract samples in critically patients. Crit Care. 2006;10:R31. doi:10.1.1186/cc4823.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Blot SI, Taccone FS, Van den Abeele AM, Bulpa P, Meersseman W, Brusselaers N, et al. A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically patients. Am J Respir Crit Care Med. 2012;186:56–64.

    Article  PubMed  Google Scholar 

  11. Pagano L, Caira M, Picardi M, Candoni A, Melillo L, Fianchi L, et al. Invasive aspergillosis in patients with acute leukemia: update on morbidity and mortality—SEIFEM-C Report. Clin Infect Dis. 2007;1:1524–5.

    Article  Google Scholar 

  12. Nucci M, Nouér SA, Grazziutti M, et al. Probable invasive aspergillosis without prespecified radiological findings: proposal for inclusion of a new category of aspergillosis and implications for studying novel therapies. Clin Infect Dis. 2010;51:1273–80.

    Article  PubMed  Google Scholar 

  13. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis. 2002;34:7–14.

    Article  CAS  PubMed  Google Scholar 

  14. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the european organization for research and treatment of cancer/invasive fungal infections cooperative group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008;46:1813–21.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Tsitsikas DA, Morin A, Araf S, Murtagh B, Johnson G, Vinnicombe S, et al. Impacted of the revised (2008) EORTC/MSG definitions for invasive fungal disease of the rates of diagnosis of invasive aspergillosis. Med Mycol. 2012;50:538–42.

    Article  PubMed  Google Scholar 

  16. Girmenia C, Guerrisi P, Frustaci AM, Fama A, Finolezzi E, Perrone S, et al. New category of probable invasive pulmonary in hematological patients. Clin Microbiol Infect. 2012;18:990–6.

    Article  CAS  PubMed  Google Scholar 

  17. Tutar N, Metan G, Koc AN, Yilmaz I, Bozkurt I, Simsek ZO, et al. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Multidiscip Respir Med. 2013;8:59. doi:10.1186/2049-6958-8-59.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Alastruey-Izquierdo A, Mellado E, Peláez T, et al. Population-based survey of filamentous fungi and antifungal resistance in Spain (FILPOP STUDY). Antimicrob Agents Chemother. 2013;57:3380–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Marchetti O, Lamoth F, Mikulska M, Viscoli C, Verweij P, Bretagne S. ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients. Bone Marrow Transplant. 2012;47:846–54.

    Article  CAS  PubMed  Google Scholar 

  20. Prattes J, Flick H, Prüller F, et al. Novel test for diagnosis of invasive aspergillosis in patients with underlying respiratory diseases. Am J Respir Crit Care Med. 2014;190:922–9.

    Article  CAS  PubMed  Google Scholar 

  21. Mikulska M, Furfaro E, Viscoli C. Non-cultural methods for the diagnosis of invasive fungal disease. Expert Rev Anti Infect Ther. 2015;13:103–17.

    Article  CAS  PubMed  Google Scholar 

  22. Global initiative for chronic obstructive lung disease. Pocket Guide to COPD. Diagnosis, management and prevention. Updated 2015. www.goldcopd.com.

  23. Patterson TF, Thompson GR, Denning DW, Fishman JA, Hadley S, Herbrecht R, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases Society of America. Clin Infect Dis. 2016;63:433–42.

    Article  PubMed  Google Scholar 

  24. Barouky R, Badet M, Denis M, Soubirou JL, Philit F, Guerin C. Inhaled corticosteroids in chronic obstructive pulmonary disease and disseminated aspergillosis. Eur J Intern Med. 2003;14:380–2.

    Article  CAS  PubMed  Google Scholar 

  25. Balajee SA, Kano R, Baddley JW, Moser SA, Marr KA, Alexander BD, et al. Molecular identification of aspergillus species collected for the transplant-associated infection surveillance network. J Clin Microbiol. 2009;47:3138–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Hachem RY, Kontoyiannis DP, Chemaly RF, Jiang Y, Reitzel R, Raad I. Utility of galactomannan enzyme immunoassay and (1,3) β-d-glucan in diagnosis of invasive fungal infections: low sensitivity for aspergillus fumigatus infection in hematologic malignancy patients. J Clin Microbiol. 2009;47:129–33.

    Article  CAS  PubMed  Google Scholar 

  27. Bergeron A, Porcher R, Sulahian A, de Bazelaire C, Chagnon K, Raffoux E, et al. The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies. Blood. 2012;119:1831–7.

    Article  CAS  PubMed  Google Scholar 

  28. Steinmann J, Buer J, Rath PM, Paul A, Saner F. Invasive aspergillosis in two liver transplant recipients: diagnosis by SeptiFast. Transpl Infect Dis. 2009;11:175–8.

    Article  CAS  PubMed  Google Scholar 

  29. Bravo D, Blanquer J, Tormo M, Aguilar G, Borrá R, Solano C, et al. Diagnostic accuracy and potential clinical value of the LightCycler SeptiFast assay in the management of bloodstream infections occurring in neutropenic and critically ill patients. Int J Infect Dis. 2011;15:e326–31.

    Article  PubMed  Google Scholar 

  30. Mauro MV, Cavalcantia P, Peruginia D, Noto A, Sperlì D, Giraldi C. Diagnostic utility of LightCycler SeptiFast and procalcitonin assays in the diagnosis of bloodstream infection in immunocompromised patients. Diagnostic Microbiol Infect Dis. 2012;73:308–11.

    Article  CAS  Google Scholar 

  31. Guinea J, Torres-Narbona M, Gijon P, Muñoz P, Pozo F, Peláez T, et al. Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors and outcome. Clin Microbiol Infect. 2010;16:870–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank Marta Pulido, MD, for editing the manuscript and editorial assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ana I. Aller-García.

Ethics declarations

Conflict of interest

No funding was received for this clinical study. The authors have no conflicts of interest to be declared.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aller-García, A.I., Castro-Méndez, C., Alastruey-Izquierdo, A. et al. Case Series Study of Invasive Pulmonary Aspergillosis. Mycopathologia 182, 505–515 (2017). https://doi.org/10.1007/s11046-016-0097-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11046-016-0097-1

Keywords

Navigation